• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 COVID-19 大流行期间新诊断膀胱癌患者的诊断和治疗延误。

The delay in the diagnosis and treatment of newly diagnosed bladder cancer patients during COVID 19 pandemic.

机构信息

Namik Kemal University Faculty of Medicine, Department of Urology.

Zonguldak Bulent Ecevit Universitesi Tip Fakultesi.

出版信息

Afr Health Sci. 2022 Sep;22(3):241-249. doi: 10.4314/ahs.v22i3.26.

DOI:10.4314/ahs.v22i3.26
PMID:36910348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9993310/
Abstract

BACKGROUND

To evaluate the newly diagnosed bladder cancer(BC) patients during the pandemic period and compare them with the corresponding last4 years.

OBJECTIVES

To document the time schedules of BC patient evaluation and define the possible delays and investigate the reasons.

METHODS

Newly diagnosed BC patients who underwent transurethral resection of bladder tumour in the last5 years were retrospectively included to study. The patients were divided into 5 groups. Group-1 was composed of patients diagnosed betweenMarch, 1,2016 -March-1,2017. The patients who were diagnosed in the further corresponding years formed group 2,3 and 4. The last group(Group-5) was composed of patients who were diagnosed during the pandemic period which was between March,1,2020 and March,1,2021. The clinicodemographic properties and diagnostic time schedules of the patients were compared between the groups.

RESULTS

There were56 patients in Group-1,60 patients in Group-2,61 patients in Group-3,68 patients in Group-4, and 58 patients inGroup-5. The mean hospital admission period was102.5±179.0days during the pandemic period which ranged between24.5± 32.0 and38.3±69.1days before thepandemic.(p=0.002)The diagnosis-anesthesia period was significantly higher during the pandemic pandemic period.(p=0.034).

CONCLUSIONS

The pandemic period has caused some delays in the diagnosis and treatment of BC patients. Telemonitoring systems may be useful to prevent the possible diagnostic and treatment delays for newly diagnosed BC patients.

摘要

背景

评估大流行期间新诊断的膀胱癌(BC)患者,并将其与过去 4 年的相应患者进行比较。

目的

记录 BC 患者评估的时间安排,确定可能的延迟并调查原因。

方法

回顾性纳入过去 5 年内接受经尿道膀胱肿瘤切除术的新诊断 BC 患者进行研究。患者被分为 5 组。第 1 组由 2016 年 3 月 1 日至 2017 年 3 月 1 日诊断的患者组成。进一步对应的年份诊断的患者形成第 2、3 和 4 组。最后一组(第 5 组)由大流行期间诊断的患者组成,时间为 2020 年 3 月 1 日至 2021 年 3 月 1 日。比较各组患者的临床病理特征和诊断时间安排。

结果

第 1 组有 56 例患者,第 2 组有 60 例患者,第 3 组有 61 例患者,第 4 组有 68 例患者,第 5 组有 58 例患者。大流行期间的平均住院时间为 102.5±179.0 天,大流行前为 24.5±32.0 天至 38.3±69.1 天(p=0.002)。诊断-麻醉期在大流行期间明显更高(p=0.034)。

结论

大流行期间导致 BC 患者的诊断和治疗出现一些延迟。远程监测系统可能有助于防止新诊断的 BC 患者可能出现的诊断和治疗延迟。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf6/9993310/49725eee7cd4/AFHS2203-0241Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf6/9993310/49725eee7cd4/AFHS2203-0241Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf6/9993310/49725eee7cd4/AFHS2203-0241Fig1.jpg

相似文献

1
The delay in the diagnosis and treatment of newly diagnosed bladder cancer patients during COVID 19 pandemic.在 COVID-19 大流行期间新诊断膀胱癌患者的诊断和治疗延误。
Afr Health Sci. 2022 Sep;22(3):241-249. doi: 10.4314/ahs.v22i3.26.
2
How has the COVID-19 pandemic affected patients with primary bladder cancer?新冠肺炎疫情如何影响原发性膀胱癌患者?
Cir Cir. 2023;91(2):204-211. doi: 10.24875/CIRU.22000204.
3
Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients.COVID-19 大流行对突尼斯患者诊断时乳腺癌病理分期的影响。
Breast Dis. 2024;43(1):9-17. doi: 10.3233/BD-230051.
4
Gastric cancer diagnosis and staging in coronavirus disease 2019 (Covid-19) pandemic.在 2019 冠状病毒病(COVID-19)大流行期间的胃癌诊断和分期。
Ann Ital Chir. 2023;94:203-208.
5
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy.在大流行期间管理肌层浸润性膀胱癌:接受根治性同期放化疗的患者治疗延迟对生存结果的影响。
Clin Genitourin Cancer. 2021 Feb;19(1):41-46.e1. doi: 10.1016/j.clgc.2020.06.005. Epub 2020 Jun 22.
6
Delayed diagnosis and increased mortality risk: Assessing the effects of the COVID-19 pandemic on breast cancer recurrence.延迟诊断和增加死亡风险:评估 COVID-19 大流行对乳腺癌复发的影响。
Clinics (Sao Paulo). 2024 Mar 2;79:100340. doi: 10.1016/j.clinsp.2024.100340. eCollection 2024.
7
Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic.在 COVID-19 大流行期间,接受根治性膀胱切除术的患者中,加速康复外科(ERAS)方案暂停的临床影响。
Actas Urol Esp (Engl Ed). 2023 Jul-Aug;47(6):369-375. doi: 10.1016/j.acuroe.2023.01.006. Epub 2023 Feb 24.
8
Impact of the COVID-19 pandemic on bladder cancer patients: a multicenter real-world study.COVID-19 大流行对膀胱癌患者的影响:一项多中心真实世界研究。
J Int Med Res. 2023 Oct;51(10):3000605231204465. doi: 10.1177/03000605231204465.
9
Racial Disparities in Breast Cancer Presentation and Diagnosis in COVID-Era Central Texas.新冠疫情时期德克萨斯州中部的乳腺癌临床表现和诊断中的种族差异。
J Surg Res. 2023 Aug;288:79-86. doi: 10.1016/j.jss.2023.02.021. Epub 2023 Mar 20.
10
A retrospective cohort study of bladder cancer following the COVID-19 pandemic: Are patients presenting with more aggressive disease?一项关于新冠疫情后膀胱癌的回顾性队列研究:患者所患疾病是否更具侵袭性?
Ann Med Surg (Lond). 2022 Sep;81:104430. doi: 10.1016/j.amsu.2022.104430. Epub 2022 Aug 18.

引用本文的文献

1
A novel artificial intelligence segmentation model for early diagnosis of bladder tumors.一种用于膀胱肿瘤早期诊断的新型人工智能分割模型。
Abdom Radiol (NY). 2024 Dec 30. doi: 10.1007/s00261-024-04715-9.
2
Association between time to treatment and bladder cancer survival: a population-based analysis.治疗时间与膀胱癌生存率之间的关联:一项基于人群的分析。
Transl Androl Urol. 2024 Sep 30;13(9):2079-2091. doi: 10.21037/tau-24-148. Epub 2024 Sep 26.
3
Effects of delayed diagnosis on tumor size, stage and grade in bladder cancer.延迟诊断对膀胱癌肿瘤大小、分期及分级的影响。

本文引用的文献

1
Delayed Urological Cancer Care during the COVID-19 Pandemic: Urologists' Experience.COVID-19大流行期间泌尿外科癌症的延迟治疗:泌尿外科医生的经验
Urol Pract. 2021 May;8(3):367-372. doi: 10.1097/UPJ.0000000000000210. Epub 2021 Mar 26.
2
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis.2019冠状病毒病大流行对高危非肌层浸润性膀胱癌患者初次、二次切除及辅助膀胱内治疗时间的影响:一项回顾性多机构队列分析
Cancers (Basel). 2021 Oct 21;13(21):5276. doi: 10.3390/cancers13215276.
3
Int Urol Nephrol. 2024 Mar;56(3):935-940. doi: 10.1007/s11255-023-03829-1. Epub 2023 Oct 17.
4
Editorial I: So, who wins? It is still: NCDs 3; Infections 2.社论一:那么,谁赢了呢?仍然是:非传染性疾病3分;传染病2分。
Afr Health Sci. 2022 Sep;22(3):i-v. doi: 10.4314/ahs.v22i3.1.
Effect of COVID-19 Pandemic on Diagnosis and Treatment Delays in Urological Disease: Single-Institution Experience.
2019年冠状病毒病大流行对泌尿系统疾病诊断和治疗延误的影响:单机构经验
Risk Manag Healthc Policy. 2021 Mar 4;14:895-900. doi: 10.2147/RMHP.S299233. eCollection 2021.
4
How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d'Aosta Oncological Network, Italy.COVID-19 紧急事件对泌尿肿瘤学有何影响?来自意大利皮埃蒙特/瓦莱达奥斯塔肿瘤网络的数据。
Urologia. 2021 Feb;88(1):3-8. doi: 10.1177/0391560320946186.
5
Effect of Coronavirus Disease 2019 on Patients with Bladder Cancer in China.2019年冠状病毒病对中国膀胱癌患者的影响。
Urol Int. 2021;105(7-8):726-728. doi: 10.1159/000512895. Epub 2021 Feb 24.
6
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?新冠疫情如何能给泌尿外科住院医师培训带来积极变化?
Front Surg. 2020 Nov 24;7:563006. doi: 10.3389/fsurg.2020.563006. eCollection 2020.
7
Cancer Diagnostic Delay in Northern and Central Italy During the 2020 Lockdown Due to the Coronavirus Disease 2019 Pandemic.意大利北部和中部地区 2020 年因新冠疫情 lockdown 期间的癌症诊断延误。
Am J Clin Pathol. 2021 Jan 4;155(1):64-68. doi: 10.1093/ajcp/aqaa177.
8
Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology.2020 年因 COVID-19 大流行而实行的“封锁”期间的癌症诊断率与 2018-2019 年相比:一项来自细胞病理学的审计研究。
J Clin Pathol. 2021 Mar;74(3):187-189. doi: 10.1136/jclinpath-2020-206833. Epub 2020 Jun 19.
9
SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?严重急性呼吸综合征冠状病毒2感染与高危非肌层浸润性膀胱癌:有哪些共同特征?
Urol Int. 2020;104(7-8):510-522. doi: 10.1159/000509065. Epub 2020 Jun 9.
10
Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients' Perspective.新冠疫情期间泌尿科的远程医疗在线就诊:潜力、风险因素和患者视角。
Eur Urol. 2020 Jul;78(1):16-20. doi: 10.1016/j.eururo.2020.04.055. Epub 2020 Apr 27.